About
Cipher Pharmaceuticals Inc (TO:CPH) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 12 2026
Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings
Mar 4 2026
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call
Jan 28 2026
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)
Jan 28 2026
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)
Nov 6 2025
Cipher Pharmaceuticals Reports Third Quarter 2025 Results
Financials
Revenue
CA$50.45 M
Market Cap
CA$485.32 M
P/E Ratio
13.10
EPS
1.46
Google Übersetzer